Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie A Lebrun

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|February 1, 2002
Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A familyLaurie A LeBrun, Ute Hoch, Paul R Ortiz de Montellano
Biochemistry|March 9, 2005
The P450cam G248E mutant covalently binds its prosthetic heme groupJulian Limburg, Laurie A LeBrun, Paul R Ortiz de Montellano
Biochemistry|March 17, 2004
Participation of histidine-51 in catalysis by horse liver alcohol dehydrogenaseLaurie A LeBrun, Doo-Hong Park, S Ramaswamy, et al.
Biochemistry|May 1, 2002
Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 familyLaurie A LeBrun, Fengyun Xu, Deanna L Kroetz, et al.
Assay and Drug Development Technologies|March 14, 2008
ATLAS--a high-throughput affinity-based screening technology for soluble proteins: technology application using p38 MAP kinaseRupal Patel, Laurie A Lebrun, Shaohui Wang, et al.
European Journal of Biochemistry|June 20, 2002
Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetryMaria J Hernaiz, Laurie A LeBrun, Yi Wu, et al.
Journal of Medicinal Chemistry|February 16, 2021
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid LeukemiaJoshua D Hansen, Matthew Correa, Matt Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Zhongxiang Sun, Benjamin K Ayida, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituentsPeter S Dragovich, Julie K Blazel, David A Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|February 1, 2002
Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A familyLaurie A LeBrun, Ute Hoch, Paul R Ortiz de Montellano
Biochemistry|March 9, 2005
The P450cam G248E mutant covalently binds its prosthetic heme groupJulian Limburg, Laurie A LeBrun, Paul R Ortiz de Montellano
Biochemistry|March 17, 2004
Participation of histidine-51 in catalysis by horse liver alcohol dehydrogenaseLaurie A LeBrun, Doo-Hong Park, S Ramaswamy, et al.
Biochemistry|May 1, 2002
Covalent attachment of the heme prosthetic group in the CYP4F cytochrome P450 familyLaurie A LeBrun, Fengyun Xu, Deanna L Kroetz, et al.
Assay and Drug Development Technologies|March 14, 2008
ATLAS--a high-throughput affinity-based screening technology for soluble proteins: technology application using p38 MAP kinaseRupal Patel, Laurie A Lebrun, Shaohui Wang, et al.
European Journal of Biochemistry|June 20, 2002
Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetryMaria J Hernaiz, Laurie A LeBrun, Yi Wu, et al.
Journal of Medicinal Chemistry|February 16, 2021
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid LeukemiaJoshua D Hansen, Matthew Correa, Matt Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Zhongxiang Sun, Benjamin K Ayida, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituentsPeter S Dragovich, Julie K Blazel, David A Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.
Pageof 2